Evaluation of hepcidin isoforms in hemodialysis patients by a proteomic approach based on SELDI-TOF MS

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Castagna, Annalisa ^a   Campostrini, Natascia ^a   Zaninotto, Federica ^a   Bedogna, Valeria ^b   Tessitore, Nicola ^b   Poli, Albino ^b   Martinelli, Nicola ^a   Lupo, Antonio ^b   Olivieri, Oliviero ^a   Girelli, Domenico ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; FERRITIN; HEPCIDIN; HEPCIDIN 20; HEPCIDIN 25; IRON; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG; ANTIMICROBIAL CATIONIC PEPTIDE; HEPCIDIN (6 25), HUMAN; HEPCIDIN (6-25), HUMAN; HEPCIDIN 25, HUMAN; ISOPROTEIN; PEPTIDE FRAGMENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; GEOMETRY; HEMODIALYSIS PATIENT; HUMAN; INFLAMMATION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; PROTEOMICS; QUANTITATIVE ANALYSIS; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TREATMENT DURATION; BLOOD; CASE CONTROL STUDY; MASS SPECTROMETRY; METHODOLOGY; MIDDLE AGED; RENAL REPLACEMENT THERAPY; STATISTICAL MODEL;

ADULT; AGED; ANTIMICROBIAL CATIONIC PEPTIDES; CASE-CONTROL STUDIES; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PROTEIN ISOFORMS; PROTEOMICS; RENAL DIALYSIS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 77952502655     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/329646     Document Type: Article

References (25)

1. Ganz T., Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation Blood 2003 102 3 783 788
2. Nemeth E., Tuttle M. S., Powelson J., Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization Science 2004 306 5704 2090 2093
3. Park C. H., Valore E. V., Waring A. J., Ganz T., Hepcidin, a urinary antimicrobial peptide synthesized in the liver Journal of Biological Chemistry 2001 276 11 7806 7810
4. De Domenico I., Nemeth E., Nelson J. M., The hepcidin-binding site on ferroportin is evolutionarily conserved Cell Metabolism 2008 8 2 146 156
5. Suzuki H., Toba K., Kato K., Serum hepcidin-20 is elevated during the acute phase of myocardial infarction Tohoku Journal of Experimental Medicine 2009 218 2 93 98
6. Piperno A., Mariani R., Trombini P., Girelli D., Hepcidin modulation in human diseases: from research to clinic World Journal of Gastroenterology 2009 15 5 538 551
7. Kiehntopf M., Siegmund R., Deufel T., Use of SELDI-TOF mass spectrometry for identification of new biomarkers: potential and limitations Clinical Chemistry and Laboratory Medicine 2007 45 11 1435 1449
8. Bons J. A., Wodzig W. K., van Dieijen-Visser M. P., Protein profiling as a diagnostic tool in clinical chemistry: a review Clinical Chemistry and Laboratory Medicine 2005 43 12 1281 1290
9. Swinkels D. W., Girelli D., Laarakkers C., Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry PLoS ONE 2008 3 7, article e2706
10. Girelli D., De Domenico I., Bozzini C., Clinical, pathological, and molecular correlates in ferroportin disease: a study of two novel mutations Journal of Hepatology 2008 49 4 664 671
11. Robach P., Recalcati S., Girelli D., Alterations of systemic and muscle iron metabolism in human subjects treated with low-dose recombinant erythropoietin Blood 2009 113 26 6707 6715
12. Bozzini C., Campostrini N., Trombini P., Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis Blood Cells, Molecules, and Diseases 2008 40 3 347 352
13. Malyszko J., Mysliwiec M., Hepcidin in anemia and inflammation in chronic kidney disease Kidney and Blood Pressure Research 2007 30 1 15 30
14. Hamada Y., Fukagawa M., Is hepcidin the star player in iron metabolism in chronic kidney disease Kidney International 2009 75 9 873 874
15. Nemeth E., Rivera S., Gabayan V., IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin Journal of Clinical Investigation 2004 113 9 1271 1276
16. Valenti L., Girelli D., Valenti G. F., HFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patients Clinical Journal of the American Society of Nephrology 2009 4 8 1331 1337
17. Ashby D. R., Gale D. P., Busbridge M., Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease Kidney International 2009 75 9 976 981
18. Weiss G., Theurl I., Eder S., Serum hepcidin concentration in chronic haemodialysis patients: associations and effects of dialysis, iron and erythropoietin therapy European Journal of Clinical Investigation 2009 39 10 883 890
19. Zaritsky J., Young B., Wang H.-J., Hepcidina potential novel biomarker for iron status in chronic kidney disease Clinical Journal of the American Society of Nephrology 2009 4 6 1051 1056
20. Zucchelli P., Santoro A., Raggiotto G., Biofiltration in uremia: preliminary observations Blood Purification 1984 2 4 187 195
21. Wratten M. L., Ghezzi P. M., Hemodiafiltration with endogenous reinfusion Contributions to Nephrology 2007 158 94 102
22. Kemna E. H. J. M., Tjalsma H., Podust V. N., Swinkels D. W., Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications Clinical Chemistry 2007 53 4 620 628
23. Young B., Zaritsky J., Hepcidin for clinicians Clinical Journal of the American Society of Nephrology 2009 4 8 1384 1387
24. Tomosugi N., Kawabata H., Wakatabe R., Detection of serum hepcidin in renal failure and inflammation by using ProteinChip System Blood 2006 108 4 1381 1387
25. Kaysen G. A., The microinflammatory state in uremia: causes and potential consequences Journal of the American Society of Nephrology 2001 12 7 1549 1557